This study is in progress, not accepting new patients
Trial in Adult Subjects With Spinocerebellar Ataxia
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Michael Geschwind
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Michael Geschwind
Dr. Geschwind received his M.D.and Ph.D. in neuroscience through the National Institutes of Health (NIH)-sponsored Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine in New York.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- ID
- NCT02960893
- Phase
- Phase 2/3 Spinocerebellar Ataxia Research Study
- Study Type
- Interventional
- Participants
- About 141 people participating
- Last Updated